ESC Premium Access

Omega-3 fatty acids differentially alter the expression of detoxification enzymes and nitric oxide bioavailability in endothelial cells during IL-6 exposure

Presentation

About the speaker

Professor Preston Mason

Brigham And Women'S Hospital, Harvard Medical School, Boston (United States of America)
2 presentations
0 follower

202 more presentations in this session

Monounsaturated fatty acid antagonizes saturated fatty acid-induced cardiomyopathy via improving membrane fatty acid composition and endoplasmic reticulum stress

Speaker: Doctor T. Yamamoto (Tokyo, JP)

Thumbnail

MicroRNA let-7a, -7e and -133a attenuate hypoxia-induced atrial fibrosis via targeting collagen expression and the JNK pathway in HL1 cardiomyocytes

Speaker: Doctor C. Lo (Taichung, TW)

Thumbnail

Acute administration of the olive constituent, oleuropein, combined with post-conditioning mechanism exerts cardioprotective effects by modulating oxidative defense

Speaker: Professor I. Andreadou (Athens, GR)

Thumbnail

Coronary artery cavitation as a trigger for atherosclerotic plaque progression: a numerical and computational fluid dynamic demonstration

Speaker: Associate Professor G. Rigatelli (Rovigo, IT)

Thumbnail

Melatonin receptor blockade slows ventricular conduction by IK1 downregulation

Speaker: Doctor M. Gonotkov (Syktyvkar, RU)

Thumbnail

Access the full session

Basic science e-posters

Speakers: Professor P. Mason, Doctor T. Yamamoto, Doctor C. Lo, Professor I. Andreadou, Associate Professor G. Rigatelli...
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ESC Premium Access

Cardiovascular benefits outweigh risks in patients with atrial fibrillation in REDUCE-IT (Reduction of Cardiovascular Events with Icosapent Ethyl-Intervention Trial)

27 August 2021

ESC Premium Access

REDUCE-IT PRIOR MI: Reduction in Ischemic Events, Including Cardiovascular Mortality, with Icosapent Ethyl in Patients with Prior Myocardial Infarction

27 August 2021

ESC Premium Access

Benefits of SGLT2-1/2 Inhibition on Heart Failure, Ischemic, and Kidney Endpoints

27 August 2021

This platform is supported by

logo Novo Nordisk